Proven analytical capabilities for ADC manufacturing

We are recognized for our industry-leading expertise. Our clients get access to a global network of development and manufacturing sites in North America, Europe and Asia. A dedicated team will support you with new method development or optimization, method transfers and qualification/validation:

  • Cleaning (swab/rinse by TOC; conductivity)
  • Complete analytical development packages
  • DS/DP release testing and stability testing

And much more.

woman tech pipetting
Complete access to a broad range of analytical techniques

For your ADC drug substance and drug product release and stability testing stages, we provide you with access to our team, and a range of analytical approaches, including:

  • HPLC (e.g. SEC, HIC, RP)
  • CE (e.g. CE-SDS)
  • icIEF (charge heterogeneity)
  • LC-MS
  • UV (e.g. for protein concentration)
  • Cell-based potency assays, including establishment of cell banks

And much more.

tech working on computer

Our locations

Locations where this service is provided

Visp, Switzerland

Founded in 1897, Lonza today is a dedicated strategic manufacturing partner to the healthcare industry, working with customers in the pharma, biotech and nutrition markets. Visp remains our largest site in a global network of more than 30 sites and one of the most significant for research and development and manufacturing.

Our Visp site is a complex of industry-leading facilities specializing in the development and manufacture of products for pharmaceutical applications including mammalian and microbial biopharmaceuticals, small molecules, highly potent APIs, peptides and bioconjugates including antibody-drug conjugates (ADCs). It is also home to our pioneering Ibex® Solutions services offering. Ibex® Solutions enables customers to accelerate their path throughout the complete biopharmaceutical lifecycle - from preclinical to commercial stages, from drug substance to drug product, all in one location.

Learn more

Regulatory expertise
Pathway to success in Regulatory filings
Related Insights